Canadian Breast Cancer Foundation   Report issue

Foundation Phase 2 Phase 4
Founded: Toronto Canada (1986)

Organization Overview

First Clinical Trial
2009
NCT01344967
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Canadian Breast Cancer Foundation | Canadian Breast Cancer Foundation, Ontario Region (funder)